逸達

-0.30 (-0.37%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

80.80161成交張數577.14本益比10.00股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	19	13	31.5%	8.98	8.08	2.0%	1.3%	0.3	0.3
2026Q1	19	14	28.2%	13.61	8.85	-13.5%	-10.0%	-1.8	-1.8
2025Q4	13	9	29.1%	3.44	5.90	-69.8%	-50.9%	-1.4	-1.4
2025Q3	16	11	32.4%	3.67	6.75	-138.7%	-80.7%	-2.6	-2.6
2025Q2	16	10	37.9%	2.92	6.28	-144.0%	-89.9%	-1.6	-1.6
2025Q1	17	13	22.1%	6.52	8.58	-101.2%	-74.0%	-2.9	-2.9
2024Q4	22	16	25.9%	4.62	10.33	-76.0%	-53.8%	-6.6	-6.6
2024Q3	15	7	51.9%	1.88	5.15	-81.7%	-52.0%	-2.6	-3.8
2024Q2	16	10	37.2%	2.67	7.36	-61.5%	-43.9%	-1.0	-1.2
2024Q1	17	11	31.8%	3.63	8.46	-103.0%	-70.7%	-1.6	-1.7
2023Q4	19	12	33.1%	3.38	9.16	-96.2%	-65.5%	-3.0	-3.2
2023Q3	21	16	25.5%	6.45	11.60	-67.6%	-51.1%	-2.1	-2.1
2023Q2	23	18	22.6%	7.26	13.22	-54.8%	-42.8%	-1.9	-2.0
2023Q1	11	7	30.8%	9.73	6.31	-54.1%	-40.0%	-1.8	-2.0
2022Q4	13	9	30.2%	7.08	7.71	-42.4%	-32.1%	-2.1	-2.4
2022Q3	14	11	22.6%	13.44	9.36	-35.4%	-28.3%	-1.0	-1.1
2022Q2	16	12	20.7%	14.98	10.56	-32.3%	-26.4%	1.4	1.4
2022Q1	16	12	23.0%	10.70	10.27	-36.8%	-30.3%	-0.7	-0.7
2021Q4	16	13	19.6%	17.51	11.19	-36.1%	-30.4%	-1.4	-1.4
2021Q3	18	15	18.1%	18.41	12.61	-42.2%	-33.1%	-1.4	-1.4
2021Q2	20	16	16.3%	21.44	14.00	-40.0%	-33.6%	2.1	2.1
2021Q1	19	17	13.7%	18.76	14.32	-45.3%	-39.5%	-1.4	-1.5
2020Q4	21	18	12.9%	13.87	15.64	-37.5%	-32.9%	-1.5	-1.5
2020Q3	8	6	28.8%	2.98	5.43	-71.1%	-55.8%	-2.4	-2.4
2020Q2	8	7	15.0%	5.13	6.47	-58.3%	-50.2%	-1.5	-1.5
2020Q1	9	8	11.0%	8.65	7.88	-88.5%	-70.6%	-1.4	-1.5
2019Q4	10	9	11.2%	8.70	8.93	-69.9%	-59.6%	-1.0	-1.7
2019Q3	12	10	16.6%	5.55	9.81	-68.9%	-60.0%	-1.4	-1.4
2019Q2	13	12	13.3%	7.76	11.55	–	–	-2.2	-2.2
2019Q1	7	5	32.3%	1.85	5.27	–	–	0.1	0.0
2018Q4	6	5	20.2%	2.55	5.65	–	–	-0.8	-0.9
2018Q3	7	7	6.8%	10.86	7.54	–	–	–	–